Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ASH 2025

6 - 8 Dec 2025
Orange County Convention Center, Orlando, United States of America
Videos
News
New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights...
Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA
New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types ( Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA )
10 Dec 2025
Tec-Dara significantly improves PFS and OS compared to SoC in relapsed...
Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA
Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )
10 Dec 2025
Racial disparities in AML: Black patients show inferior survival despite...
Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine...
Racial disparities in AML: Black patients show inferior survival despite similar cytogenetics and treatment response ( Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA )
10 Dec 2025
Asciminib shows high molecular response and favourable safety in 2L chronic...
Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA
Asciminib shows high molecular response and favourable safety in 2L chronic myeloid leukaemia (CML-CP) ( Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA )
10 Dec 2025
Rocbrutinib shows strong responses in resistant CLL, including BTKi- and...
Prof Jennifer Woyach - The Ohio State University, Columbus, USA
Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
10 Dec 2025
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
Prof Jennifer Woyach - The Ohio State University, Columbus, USA
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
10 Dec 2025
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive...
Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center...
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses ( Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Dec 2025

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation